Orasure Technologies Inc (OSUR): Shareholders' Equity
$340.83M
As of 2025-12-31
$317.78M
As of 2026-06-30
-2.2%
3-year compound annual growth
-3.1%
5-year compound annual growth
+7.9%
10-year compound annual growth
| Period ended | Shareholders' Equity | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $340.83M | -16.9% | 2026-03-09, Balance as of period end |
| 2024-12-31 | $410.34M | -4.7% | 2026-03-09, Balance as of period end |
| 2023-12-31 | $430.67M | +18.2% | 2026-03-09, Balance as of period end |
| 2022-12-31 | $364.43M | -4.2% | 2025-03-07, Balance as of period end |
| 2021-12-31 | $380.53M | -4.5% | 2024-03-11, Balance as of period end |
| 2020-12-31 | $398.57M | +29.8% | 2023-03-03, Balance as of period end |
| 2019-12-31 | $307.14M | +8.4% | 2022-03-01, Balance as of period end |
| 2018-12-31 | $283.38M | +9.8% | 2021-03-01, Balance as of period end |
| 2017-12-31 | $258.08M | +38.9% | 2020-03-02, Balance as of period end |
| 2016-12-31 | $185.85M | +16.6% | 2019-02-28, Balance as of period end |
| 2015-12-31 | $159.44M | +0.5% | 2018-02-28, Balance as of period end |
| 2014-12-31 | $158.70M | -1.5% | 2017-03-14, Balance as of period end |
| 2013-12-31 | $161.15M | -5.4% | 2016-03-14, Balance as of period end |
| 2012-12-31 | $170.31M | +69.9% | 2015-03-12, Balance as of period end |
| 2011-12-31 | $100.25M | -2.5% | 2014-03-14, Balance as of period end |
| 2010-12-31 | $102.84M | -0.9% | 2013-03-13, Balance as of period end |
| 2009-12-31 | $103.81M | n/a | 2012-03-14, Balance as of period end |
Shareholders' Equity at similar companies
| Company | Year ended | Shareholders' Equity | Change YoY |
|---|---|---|---|
| Orasure Technologies Inc (OSUR) | 2025-12-31 | $340.83M | -16.9% |
| Anika Therapeutics, Inc. (ANIK) | 2025-12-31 | $143.47M | -6.8% |
| Beta Bionics, Inc. (BBNX) | 2025-12-31 | $287.61M | n/m |
| NeuroPace Inc (NPCE) | 2025-12-31 | $19.03M | +137.5% |
| Xtant Medical Holdings, Inc. (XTNT) | 2025-12-31 | $50.95M | +18.6% |
| Kestra Medical Technologies, Ltd. (KMTS) | 2026-04-30 | $259.66M | +26.4% |
| InfuSystem Holdings, Inc (INFU) | 2025-12-31 | $57.33M | -0.4% |
| Pulmonx Corp (LUNG) | 2025-12-31 | $54.12M | -36.9% |
| Neuronetics, Inc. (STIM) | 2025-12-31 | $22.38M | -19.2% |
Compare OSUR, ANIK, BBNX, NPCE side by side · Screen every company in Surgical & Medical Instruments & Apparatus ↗